EUCTR2009-017051-10-NL进行中（未招募）不适用
Metabolic adverse events before and after glucocorticoid pulse therapy in rheumatoid arthritis
MC Utrecht0 个研究点开始时间: 2010年5月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Rheumatoid arthritis exacerbation, defined by Disease Activity Score of 5.1 or higher.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Clinical contra-indication for glucocorticoid pulse therapy.
- •-Pre-existent diabetes (irrespective of medication).
研究者
相似试验
撤回
不适用
Metabolic adverse events before and after glucocorticoid pulse therapy in rheumatoid arthritisrheumatoid arthritisrheumatic disease100184241000381610023213NL-OMON35669niversitair Medisch Centrum Utrecht15
进行中（未招募）
1 期
Prevention of metabolic complications of glucocorticoid excess - Prevention of metabolic complications of glucocorticoid excessEUCTR2008-005708-18-GBQueen Mary University of London100
撤回
不适用
Acute cardiometabolic adverse effects during treatment with haloperidol in elderly patientsadverse effect10012221NL-OMON38934Tergooiziekenhuizen Hilversum150
撤回
不适用
Acute cardiometabolic risks during treatment with haloperidol in elderly patients.NL-OMON37239Tergooiziekenhuizen Hilversum128
招募中
不适用
Metabolic adverse events and comorbidity in chronic rheumatoid arthritis patients.rheumatoid artritiscardiovascular diseasesglucose intoleranceinsuline resistanceischemic heart diseaseheart failureNL-OMON20413Top Institute Pharma300